Research ArticleCancer

Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers

See allHide authors and affiliations

Science Translational Medicine  08 Nov 2017:
Vol. 9, Issue 415, eaao4307
DOI: 10.1126/scitranslmed.aao4307

Article Information

vol. 9 no. 415

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication July 19, 2017
  • Accepted for publication October 11, 2017

Author Information

  1. Monique B. Nilsson1,
  2. Huiying Sun1,
  3. Lixia Diao2,
  4. Pan Tong2,
  5. Diane Liu3,
  6. Lerong Li2,
  7. Youhong Fan1,
  8. Alissa Poteete1,
  9. Seung-Oe Lim4,
  10. Kathryn Howells5,
  11. Vincent Haddad5,
  12. Daniel Gomez6,
  13. Hai Tran1,
  14. Guillermo Armaiz Pena7,
  15. Lecia V. Sequist8,
  16. James C. Yang9,
  17. Jing Wang2,
  18. Edward S. Kim10,
  19. Roy Herbst11,
  20. J. Jack Lee3,
  21. Waun Ki Hong1,
  22. Ignacio Wistuba1,12,
  23. Mien-Chie Hung4,
  24. Anil K. Sood7 and
  25. John V. Heymach1,*
  1. 1Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  2. 2Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  3. 3Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  4. 4Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  5. 5AstraZeneca, Melbourn, SG8 6EE, UK.
  6. 6Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  7. 7Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  8. 8Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.
  9. 9Graduate Institute of Oncology, National Taiwan University and National Taiwan University Hospital, Taipei City 100, Taiwan.
  10. 10Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute Carolinas HealthCare System, Charlotte, NC 28204, USA.
  11. 11Section of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital, Yale, New Haven, CT 06510, USA.
  12. 12Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  1. *Corresponding author. Email: jheymach{at}mdanderson.org

Altmetric

Article usage

Article usage: November 2017 to November 2017

AbstractFullPdf
Nov 20171123115092308